Ibrutinib-Venetoclax Combination Is New Standard Regimen in Previously Untreated CLL.

Autor: Kuznar, Wayne
Zdroj: Oncology Practice Management. Jan2024, Vol. 14 Issue 1, p1-11. 2p.
Databáze: Academic Search Ultimate